ホーム › 前立腺がん › ニューヨーク › The Bronx
The Bronx、NYにおける前立腺がんの臨床試験
The Bronxとその周辺地域（約30マイル以内）の拠点で、前立腺がんに関する11件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
被験者募集中第2相
- James J. Peters VA Medical Center, Bronx, NY, The Bronx
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
被験者募集中第3相
- Montefiore Medical Center-Einstein Campus, The Bronx
- Montefiore Medical Center - Moses Campus, The Bronx
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
被験者募集中第3相
- Montefiore Einstein Comprehensive Cancer Center, The Bronx
- Montefiore Medical Center- Montefiore Medical Park, The Bronx
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
被験者募集中第2/3相
- Montefiore Medical Center, The Bronx
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
被験者募集中第3相
- Montefiore Medical Center, The Bronx
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
被験者募集中第3相
- Montefiore Medical Center-Einstein Campus, The Bronx
- Montefiore Medical Center-Weiler Hospital, The Bronx
- Montefiore Medical Center - Moses Campus, The Bronx
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
被験者募集中第1相
- Montefiore Medical Center, The Bronx
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
被験者募集中第3相
- Montefiore Medical Center-Einstein Campus, The Bronx
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
被験者募集中第2相
- James J. Peters VA Medical Center, The Bronx
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
被験者募集中第4相
- Montefiore Medical Center, The Bronx
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
被験者募集中第3相
- Montefiore Medical Center-Einstein Campus, The Bronx
- Montefiore Medical Center - Moses Campus, The Bronx
他の都市における前立腺がんの試験
- New York City, NY103件の研究
- Houston, TX76件の研究
- Los Angeles, CA61件の研究
- Boston, MA59件の研究
- St. Louis, MO46件の研究
- Chicago, IL45件の研究
- San Francisco, CA45件の研究
- Philadelphia, PA44件の研究
- Baltimore, MD43件の研究
- Nashville, TN43件の研究
- Seattle, WA42件の研究
- Washington, DC38件の研究
The Bronxにおける他の研究
- 非小細胞肺癌25件の研究
- 乳がん17件の研究
- 急性骨髄性白血病15件の研究
- 肺がん13件の研究
- がん（全種類）12件の研究
- 心血管疾患12件の研究
- 心不全11件の研究
- 転移性癌9件の研究
- 大腸癌9件の研究
- 頭頸部扁平上皮癌9件の研究
- 骨髄異形成症候群9件の研究
- 喘息9件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。